Merck is a leading science and technology company in healthcare, life science and performance materials. Around 58,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2020, Merck generated sales of €17.5 billion in 66 countries. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Electronics.
IIT Biotech GmbH is a service provider for next generation and third generation sequencing solutions. The availability of different sequencing platforms in close cooperation with state-of-the-art bioinformatics, allows our customers to answer individual questions in the fields of genomics, metagenomics and transcriptomics. The technological portfolio comprises short-read (Illumina) and long-read sequencing (Oxford Nanopore) and is applied to all fields of the life sciences and medicine, with a focus on customer-driven individual solutions, such as publication-ready genomes assembled from hybrid sequencing data. IIT Biotech is also the first official German service provider for Oxford Nanopore sequencing.